Nurix Therapeutics Inc.
NRIX
|
|
| |
|
| Trading Volume | 19,655 |
|
|
25.74 - 4.25 |
| Market Cap Full | $ 1.2B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 4.1% | 46.3% | -19.1% | -51.1% |
| Q2 | - | 42.1% | 12.5% | -10.4% |
| Q3 | - | 13.4% | -21.3% | 2.8% |
| Q4 | - | -32.8% | 42.7% | -15.7% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.1 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -23.5 | 56.3 | 22.3 | -10.1 | 16.1 | 31.7 | 5.5 | 13.4 | - | - | - | -14.4 |
| 2023 | |||||||||||
| 11.9 | -23.3 | -5.8 | 8.5 | 5.1 | -1.3 | -2.8 | -12.5 | -7.5 | -28.9 | 11.3 | 65.9 |
| 2022 | |||||||||||
| -35.7 | -13.2 | -12.5 | -21.7 | -8.9 | 25.6 | 22.1 | 1.4 | -16.9 | -2.3 | -2.7 | -11.4 |
| 2021 | |||||||||||
| 17.1 | -7.5 | -12.7 | 12 | -19.9 | -4.9 | 15.9 | 4.7 | -6.7 | 11.3 | -13.9 | 0.7 |
| 2020 | |||||||||||
| - | - | - | - | - | - | - | 20.6 | 49.4 | -25.7 | 64.2 | -22.9 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | -0.8 | -1 | -0.6 |
| Q2 | -0.5 | -1 | -0.6 |
| Q3 | -0.7 | -0.9 | -0.7 |
| Q4 | 0 | -0.9 | -0.9 |
| A | -1.88 | -3.7 | -2.7 |